A multitude of studies both on self-esteem and myopia control show kids as young as eight can manage contact lenses safely and competently. Insight speaks with eyecare practitioners and academics about treating this younger age group. Read more
Medicinal cannabis is often presented as an alternative treatment for glaucoma. Although there is evidence that cannabis lowers intraocular pressure, its role as a viable glaucoma therapy is limited by a short duration of action, psychotropic effects, and possible tachyphylaxis.
Opening a greenfield practice during a pandemic in Australia’s hardest-hit city has thrown up its challenges, especially when it comes to purchasing big ticket items. But DR JAYSON STONE found a way thanks to the efforts of a major supplier.
The breadth of choice in lens coatings and treatments plays to the patient’s advantage, whether they are motivated by function, fashion – or both. Insight talks shop with lens manufacturers and dispensers about market trends and retail dynamics. Read more
Choosing the frame product range can be both an exciting and stressful prospect for any independent practice. It also says a lot about a business, so it’s important to get right, writes EMMA ROBERTS. Read more
In the space of 23 years AFT Pharmaceuticals has gone from a home-based business to a multinational company. Its eyecare business is also experiencing remarkable growth, and more therapies are in the pipeline, including one for glaucoma.
Orthoptist Alina Sayer says many colleagues are reluctant to relocate to regional communities fearing a lack of support or job satisfaction. Her experience in central Queensland has been to the contrary. Read more
Staff across Ocula’s independent optometry network grew tired of their intricate appointment booking system. It’s now been streamlined thanks to a new relationship with a health service platform that’s also driving the business’s digital marketing to patients. Read more
On 1 December, the registration standard for optometrists’ CPD will change from a points-based two-year cycle to a time-based annual cycle. Insight examines the challenges this presents, how optometrists are responding and whether COVID-19 has helped or hindered the impending change-over. Read more
Keratoconus is common. In fact, it’s so prevalent that I see it most days I’m in the clinic. Read more